Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomas

  • Authors:
    • Hiroshi Okabe
    • Yoichi Furukawa
    • Tatsushi Kato
    • Suguru Hasegawa
    • Yoshio Yamaoka
    • Yusuke Nakamura
  • View Affiliations

  • Published online on: January 1, 2004     https://doi.org/10.3892/ijo.24.1.43
  • Pages: 43-48
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To disclose mechanisms of hepatocellular carcinogenesis and to identify novel diagnostic markers and/or drug targets for treatment of hepatocellular carcinomas (HCCs), we analyzed expression profiles of clinical HCCs using a genome-wide cDNA microarray. From among the transcripts that were commonly up-regulated in these tumors we identified a novel human gene at chromosomal band 1p36.13, termed DDEFL1 (development and differentiation enhancing factor-like 1), encoding a product that shared structural features with centaurin-family proteins. The deduced 903-amino acid sequence showed 46% homology to DDEF/ASAP1 (development and differentiation enhancing factor), and contained an Arf GTPase-activating protein (ArfGAP) domain and two ankyrin repeats. Gene transfer of DDEFL1 promoted proliferation of cells that lacked endogenous expression of this gene. Furthermore, reduction of DDEFL1 expression by transfection of anti-sense S-oligonucleotides inhibited the growth of SNU475 cancer cells, in which DDEFL1 expression was highly up-regulated. Our results provide novel insight into hepatocarcinogenesis and may contribute to development of new strategies for diagnosis and treatment of HCC.

Related Articles

Journal Cover

January 2004
Volume 24 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Okabe, H., Furukawa, Y., Kato, T., Hasegawa, S., Yamaoka, Y., & Nakamura, Y. (2004). Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomas. International Journal of Oncology, 24, 43-48. https://doi.org/10.3892/ijo.24.1.43
MLA
Okabe, H., Furukawa, Y., Kato, T., Hasegawa, S., Yamaoka, Y., Nakamura, Y."Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomas". International Journal of Oncology 24.1 (2004): 43-48.
Chicago
Okabe, H., Furukawa, Y., Kato, T., Hasegawa, S., Yamaoka, Y., Nakamura, Y."Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomas". International Journal of Oncology 24, no. 1 (2004): 43-48. https://doi.org/10.3892/ijo.24.1.43